Category: united states

Former Duke researcher at center of lawsuit lodges 16th retraction

ajrcmb-2016-55-issue-5-coverTwo former researchers at Duke University at the center of a lawsuit by a whistleblower to recoup millions in federal funding have lost yet another paper.

This is hardly the first retraction for Erin Potts-Kant, who used to work in the pulmonary lab of now-retired William Michael Foster. Earlier this year, a lawsuit filed by a former colleague of Potts-Kant and Foster was unsealed alleging that the pair — along with the university — included fraudulent data in materials involving more than 60 grants, worth hundreds of millions of dollars.

That is the legal side of their story. The science publishing side is that Potts-Kant and Foster have been steadily adding to their list of retractions — this paper represents her 16th, and his 13th.

Here’s the notice for “Nitric oxide mediates relative airway hyporesponsiveness to lipopolysaccharide in surfactant protein A-deficient mice:” Continue reading Former Duke researcher at center of lawsuit lodges 16th retraction

Authors retract third cancer paper for missing original data

international-journal-of-oncologyResearchers have retracted their third paper due to missing original data, following an investigation at their former institution in New York.

We’ve previously reported on two retractions of papers co-authored by Bhagavathi Narayanan and Narayanan K. Narayanan, previously based at the New York University (NYU) School of Medicine. The studies were pulled when the pair couldn’t provide original images to investigators at NYU School of Medicine. One author has blamed the lack of original data on the abrupt closure of her previous institution in 2004, after it allegedly misspent millions in federal grants. 

However, the latest retraction affects a paper published eight years later in the International Journal of Oncology. Its coauthors include Bhagavathi Narayanan, Narayanan K. Narayanan and Rajkishen Narayanan; we haven’t been able to uncover if there is a relation between them.

A spokesperson for the NYU School of Medicine sent us this statement: Continue reading Authors retract third cancer paper for missing original data

Eye researcher loses fourth paper for misconduct following Georgia, VA investigation

Azza B. El-Remessy
Azza B. El-Remessy

A biologist at the University of Georgia has lost a paper after an investigation revealed she had tampered with three images.

In 2014, Azza El-Remessy notched three retractions for a series of image errors. Now, a fourth retraction notice, and an expression of concern, explain there has been an investigation into her work. The investigation — conducted by two Georgia institutions, along with the Charlie Norwood Veterans Affairs Medical Center, where El-Remessy has additional appointments — has found evidence of misconduct.

The retraction notice for “Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration” explains:

Continue reading Eye researcher loses fourth paper for misconduct following Georgia, VA investigation

Author pulls Diabetes paper with duplicated Western blots

diabetesA researcher has retracted a paper from Diabetes after re-using some Western blots in one of the figures from other papers.

According to the retraction notice, the first and corresponding author — Eric Berglund, formerly at Vanderbilt University in Nashville, Tennessee — contacted the journal himself to report the error, for which he takes full responsibility.

Here’s the retraction notice: Continue reading Author pulls Diabetes paper with duplicated Western blots

Hospitalization of participant in child psych study prompted misconduct inquiry: Letter

Mani Pavuluri
Mani Pavuluri

The adverse event that prompted the University of Illinois at Chicago to shutter three trials by a child psychiatrist occurred when one of the study subjects was hospitalized.

According to a 2013 letter obtained by Retraction Watch through a public records request, the subject was admitted to a 10-day inpatient treatment program after exhibiting an increase in irritability and aggression, which prompted researcher Mani Pavuluri to notify the university’s Institutional Review Board (IRB) in January of that year. As a result, the university halted three studies by Pavuluri, sent out letters to 350 research subjects, and launched a misconduct inquiry.

Here’s how the document describes the event (with some details blacked out): Continue reading Hospitalization of participant in child psych study prompted misconduct inquiry: Letter

Materials researcher falsified data in two studies, probe reveals

advanced-materialsA materials journal has retracted two 2013 papers, citing an investigation at Pennsylvania State University that concluded the first author falsified data.

According to the retraction notice in Advanced Materials, Mehdi Ghaffari — formerly based at Penn State — was solely responsible for the misconduct. Ghaffari’s LinkedIn page says he finished his PhD at Penn State in 2014, and now works as an independent consultant in New York, after a stint as a postdoc at Procter and Gamble.

A Penn State spokesperson sent us this statement:  Continue reading Materials researcher falsified data in two studies, probe reveals

Can you plagiarize by mistake? In three papers?

Journal of Asian Public Policy An author who claimed that he accidentally plagiarized material in a retracted paper has lost two more — again, for plagiarism.

Earlier this year, we shared a 900-word statement in which Christopher S. Collins at Azusa Pacific University explained he unintentionally plagiarized a paper by taking notes on it — including writing down whole sentences — and using them in his own paper, forgetting the original source. Did the same thing happen three times?

We’re asking ourselves that question after finding two more retractions for Collins for plagiarism. One lists five different sources that he incorporated without attribution.

Here’s the retraction notice for “A higher education learning profile in the Asia-Pacific,” published in the Journal of Asian Public Policy:

Continue reading Can you plagiarize by mistake? In three papers?

Retracted paper linking HPV vaccine to behavioral issues republished after revisions

immunological-researchA retracted study linking the vaccine for human papillomavirus (HPV) to behavioral problems in mice has been republished by a different journal.

The paper has been significantly revised, an author told us, but it still comes the same conclusions. 

In February, the journal Vaccine temporarily removed the study without explanation, and told the authors the editor had asked for further review. Later that month, Vaccine retracted the paper, citing “serious concerns regarding the scientific soundness of the article,” and “seriously flawed” methodology. 

In July, another journal — Immunologic Research — republished the paper. The new version of the paper has been significantly changed, co-author Christopher Shaw from the University of British Columbia (UBC) told Retraction Watch:

Continue reading Retracted paper linking HPV vaccine to behavioral issues republished after revisions

Psst…did you hear? The effect of gossip on misconduct

1f55736
Brandon Vaidyanathan

If scientists are hesitant to formally report their colleagues when they suspect them of misconduct, can simply gossiping about their concerns in informal settings – at meetings, conferences, etc – clean up the literature? That’s a question Brandon Vaidyanathan and his colleagues tried to answer in “Gossip as Social Control: Informal Sanctions on Ethical Violations in Scientific Workplaces,” published last month in Social Problems. We spoke with Vaidyanathan, now the director of research at The H.E. Butt Family Foundation and Public Policy Fellow at the University of Notre Dame, about how scientists use gossip to warn others of potential misconduct – and whether it works.

Retraction Watch: What prompted you to discuss the role gossip can play in scientific misconduct? Continue reading Psst…did you hear? The effect of gossip on misconduct

Researcher pegged for misconduct in 11 papers earns 2nd retraction

clinical-cancer-researchA cancer journal has retracted a paper by a researcher who doctored data in 11 studies, according to a report by the U.S. Office of Research Integrity (ORI).

According to an investigation report released by the ORI last year, all 11 studies co-authored by Girija Dasmahapatra, formerly based at Virginia Commonwealth University (VCU) in Richmond, will either be retracted or corrected. In April, Dasmahapatra lost the first of the 11 papers flagged by the ORI in the journal Leukemia. Earlier this month, a second paper from the list was pulled by Clinical Cancer Research.

Dasmahapatra isn’t the only VCU researcher who’s been busy correcting the literature. All 11 papers mentioned in the ORI report list Steven Grant as last author; Paul Dent is a co-author of nine of these studies. Last month, we reported on a retraction in the Journal of Biological Chemistry (JBC) and a mega-correction in Molecular Pharmacology issued for papers by Grant and Dent due to problems with images. Neither paper included Dasmahapatra as a co-author.

We’ve also previously reported on four other errata for image-related issues for papers by Dent (one of which lists Grant as a co-author). Now, we’ve come across another correction in JBC for the pair, which was published last month.

First, here’s the new retraction notice from Clinical Cancer Research, which includes Grant and Dent as co-authors: Continue reading Researcher pegged for misconduct in 11 papers earns 2nd retraction